Interestingly, there was a substantial increase in CD4+CD39+ T-cells in COVID-19 patients compared to controls (30 ± 3.4 vs. 6.8 ± 0.66; p < 0.0001). This evidence concerns the gene ENTPD1 and COVID-19.